Jorge Mercado A couple of weeks ago, our top story was the initial public offering of Thousand Oaks-based Latigo Biotherapeutics, which smashed even its own highest expectations in its Aug. 6 IPO, raising $345.6 million and debuting at a share price of $18. Shares of Latigo are doing well in their first month as a…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
